Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
Psychosurgery01:30

Psychosurgery

1.6K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
1.6K
Drug Therapy01:28

Drug Therapy

246
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
246

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Beyond fear circuits: multiscale neurobiological architecture of panic disorder.

Molecular psychiatry·2026
Same author

Unveiling the Multifaceted Networks of the Left DLPFC for Precision TMS Targeting.

bioRxiv : the preprint server for biology·2025
Same author

Comparison of effectiveness of common targeting heuristics in repetitive transcranial magnetic stimulation treatment of depression.

BMJ mental health·2025
Same author

Motor-evoked potentials as biomarkers for sexual arousal?

The journal of sexual medicine·2024
Same author

<i>N</i>-Acetylcysteine and a Specialized Preventive Intervention for Individuals at High Risk for Psychosis: A Randomized Double-Blind Multicenter Trial.

Schizophrenia bulletin open·2024
Same author

Effect of prefrontal transcranial direct current stimulation on sexual arousal: A proof of concept study.

Neurophysiologie clinique = Clinical neurophysiology·2023

相关实验视频

Updated: Jan 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K

精准精神病学的未满足需求.

Philipp G Sand1,2, Timm B Poeppl3,4, Vera Roessler5

  • 1Department of Psychiatry, University of Regensburg, Regensburg 93053, Bavaria, Germany.

World journal of psychiatry
|September 11, 2025
PubMed
概括

一个特定的基因变异 (5-HTR1A) 可能无法可靠地预测抗抑郁药的反应,因为数据存在重大错误和方法问题. 需要进一步的研究,以确保个性化精神病学的遗传数据准确性.

关键词:
5-HTR1A基因是5HTR1A的基因之一.抗抑郁药的有效性 抗抑郁药的有效性在C-1019G的多态化中.大型抑郁症主要是抑郁症.进行元分析分析.

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K

相关实验视频

Last Updated: Jan 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.0K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K

科学领域:

  • 药物遗传学 药物遗传学
  • 精神病学遗传学 精神病学遗传学
  • 分子精神病学分子精神病学

背景情况:

  • 一项元分析表明,5-HTR1A促进子变体预测了抗抑郁药物反应.
  • 本次审查批判性地检查了这些说法的有效性.

研究的目的:

  • 评估5-HTR1A促进体变体作为抗抑郁药反应预测剂的可靠性.
  • 识别和解决遗传关联研究中的数据质量和方法问题.

主要方法:

  • 对5-HTR1A和抗抑郁药反应的元分析的审查.
  • 分析数据质量,原料特异性,等位基因含糊性和人口统计准确性.
  • 对遵守PRISMA和纽卡斯尔-太华尺度指南的评估.

主要成果:

  • 在原始数据中发现了重大错误,包括错误的基因原始对齐 (HTR1A与BDNF).
  • 由于DNA链模糊性和不准确的人口统计数据而导致等位基因的混.
  • 标准质量评估工具 (PRISMA,纽卡斯尔-太华) 并没有防止偏见.

结论:

  • 发现的数据错误和方法缺陷使人们对5-HTR1A变体对抗抑郁药响应的预测价值产生了怀疑.
  • 解决诸如种族聚合,数据格式和协议透明度等挑战对于可靠的遗传风险估计至关重要.
  • 目前的序列变异数据不太可能支持精神病学个性化医学策略,除非数据完整性和方法学得到显著改进.